{"title":"胰十二指肠切除术后胰腺癌局部复发的危险因素和血管特征:一项回顾性队列研究","authors":"Ting-Kai Liao, Ying Jui Chao, Wei-Hsun Lu, Ping-Jui Su, Chih-Jung Wang, Yan-Shen Shan","doi":"10.1002/cnr2.70267","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>This study aims to analyze the risk factors for local recurrence (LR) following pancreaticoduodenectomy (PD) in pancreatic cancer patients and to identify vascular features associated with this outcome.</p>\n </section>\n \n <section>\n \n <h3> Background</h3>\n \n <p>Pancreatic cancer frequently involves the mesenteric root, particularly the Porto-mesenteric vein (PV-SMV), impacting survival post curative surgery. However, the relationship between vascular structural changes and LR post-operation remains unclear.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Retrospective data collection was conducted at a single tertiary center from December 2010 to March 2021. Clinical characteristics, surgical-pathological factors, and radiological features were compiled.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 203 pancreatic cancer cases undergoing PD were analyzed, with 72 (35.5%) undergoing concurrent PV-SMV resection (VR). Median overall survival post-operation was 22.4 months. LR occurred in 121 patients (60%) at a median time of 8 months postoperatively. Resectable disease exhibited significantly longer local-recurrence free survival compared to borderline resectable/locally advanced pancreatic cancer (BRPC/LAPC) (median 14.5 vs. 7 months, <i>p</i> < 0.001). The most frequent sites of LR were the mesenteric root (37%), superior mesenteric artery (SMA, 21%), and superior mesenteric vein (SMV, 16%), with similar patterns observed in the VR and non-VR groups. BRPC, LAPC, postoperative CA19-9 above normal range, venous thrombosis, and stenosis were associated with LR (HR: 2.1 [95% CI 1.21–3.68], 2.7 [95% CI 1.6–4.71], 1.8 [95% CI 1.21–2.69], 2.0 [95% CI 1.08–3.92], and 1.6 [95% CI 1.0–2.65], respectively), while PV-SMV resection and enlargement of PV-SMV angle were protective factors (HR: 0.4 [95% CI 0.25–0.67] and 0.3 [95% CI 0.19–0.53]).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Despite aggressive treatment strategies including neoadjuvant therapy and radical surgery, LR in pancreatic cancer remains a challenge. This study highlights potential risk factors, recurrence patterns, and associated vascular features for early identification. These findings may guide clinicians in developing more targeted surveillance strategies and inform future research on preventing LR.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":"8 7","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70267","citationCount":"0","resultStr":"{\"title\":\"Risk Factors and Vascular Features Associated With Local Recurrence in Pancreatic Cancer Post-Pancreaticoduodenectomy: A Retrospective Cohort Study\",\"authors\":\"Ting-Kai Liao, Ying Jui Chao, Wei-Hsun Lu, Ping-Jui Su, Chih-Jung Wang, Yan-Shen Shan\",\"doi\":\"10.1002/cnr2.70267\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objectives</h3>\\n \\n <p>This study aims to analyze the risk factors for local recurrence (LR) following pancreaticoduodenectomy (PD) in pancreatic cancer patients and to identify vascular features associated with this outcome.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Pancreatic cancer frequently involves the mesenteric root, particularly the Porto-mesenteric vein (PV-SMV), impacting survival post curative surgery. However, the relationship between vascular structural changes and LR post-operation remains unclear.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Retrospective data collection was conducted at a single tertiary center from December 2010 to March 2021. Clinical characteristics, surgical-pathological factors, and radiological features were compiled.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 203 pancreatic cancer cases undergoing PD were analyzed, with 72 (35.5%) undergoing concurrent PV-SMV resection (VR). Median overall survival post-operation was 22.4 months. LR occurred in 121 patients (60%) at a median time of 8 months postoperatively. Resectable disease exhibited significantly longer local-recurrence free survival compared to borderline resectable/locally advanced pancreatic cancer (BRPC/LAPC) (median 14.5 vs. 7 months, <i>p</i> < 0.001). The most frequent sites of LR were the mesenteric root (37%), superior mesenteric artery (SMA, 21%), and superior mesenteric vein (SMV, 16%), with similar patterns observed in the VR and non-VR groups. BRPC, LAPC, postoperative CA19-9 above normal range, venous thrombosis, and stenosis were associated with LR (HR: 2.1 [95% CI 1.21–3.68], 2.7 [95% CI 1.6–4.71], 1.8 [95% CI 1.21–2.69], 2.0 [95% CI 1.08–3.92], and 1.6 [95% CI 1.0–2.65], respectively), while PV-SMV resection and enlargement of PV-SMV angle were protective factors (HR: 0.4 [95% CI 0.25–0.67] and 0.3 [95% CI 0.19–0.53]).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Despite aggressive treatment strategies including neoadjuvant therapy and radical surgery, LR in pancreatic cancer remains a challenge. This study highlights potential risk factors, recurrence patterns, and associated vascular features for early identification. These findings may guide clinicians in developing more targeted surveillance strategies and inform future research on preventing LR.</p>\\n </section>\\n </div>\",\"PeriodicalId\":9440,\"journal\":{\"name\":\"Cancer reports\",\"volume\":\"8 7\",\"pages\":\"\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cnr2.70267\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70267\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.70267","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的本研究旨在分析胰腺癌患者胰十二指肠切除术(PD)后局部复发(LR)的危险因素,并确定与此结果相关的血管特征。胰腺癌常累及肠系膜根,尤其是门静脉-肠系膜静脉(PV-SMV),影响术后的生存。然而,血管结构变化与术后LR的关系尚不清楚。方法2010年12月至2021年3月在某三级中心进行回顾性资料收集。汇总临床特点、手术病理因素及影像学特征。结果共分析203例行PD的胰腺癌患者,其中72例(35.5%)行PV-SMV同步切除(VR)。术后中位总生存期为22.4个月。术后中位时间为8个月,121例(60%)患者发生LR。与边缘可切除/局部晚期胰腺癌(BRPC/LAPC)相比,可切除的疾病表现出更长的局部无复发生存期(中位14.5个月vs. 7个月,p < 0.001)。最常见的LR部位是肠系膜根(37%)、肠系膜上动脉(SMA, 21%)和肠系膜上静脉(SMV, 16%),在VR组和非VR组中观察到相似的模式。BRPC、LAPC、术后CA19-9高于正常范围、静脉血栓形成和狭窄与LR相关(HR分别为2.1 [95% CI 1.21-3.68]、2.7 [95% CI 1.6 - 4.71]、1.8 [95% CI 1.21-2.69]、2.0 [95% CI 1.08-3.92]和1.6 [95% CI 1.0-2.65]),而PV-SMV切除和PV-SMV角度扩大是保护因素(HR: 0.4 [95% CI 0.25-0.67]和0.3 [95% CI 0.19-0.53])。结论尽管积极的治疗策略包括新辅助治疗和根治性手术,胰腺癌的LR仍然是一个挑战。这项研究强调了潜在的危险因素、复发模式和相关的早期识别血管特征。这些发现可以指导临床医生制定更有针对性的监测策略,并为未来预防LR的研究提供信息。
Risk Factors and Vascular Features Associated With Local Recurrence in Pancreatic Cancer Post-Pancreaticoduodenectomy: A Retrospective Cohort Study
Objectives
This study aims to analyze the risk factors for local recurrence (LR) following pancreaticoduodenectomy (PD) in pancreatic cancer patients and to identify vascular features associated with this outcome.
Background
Pancreatic cancer frequently involves the mesenteric root, particularly the Porto-mesenteric vein (PV-SMV), impacting survival post curative surgery. However, the relationship between vascular structural changes and LR post-operation remains unclear.
Methods
Retrospective data collection was conducted at a single tertiary center from December 2010 to March 2021. Clinical characteristics, surgical-pathological factors, and radiological features were compiled.
Results
A total of 203 pancreatic cancer cases undergoing PD were analyzed, with 72 (35.5%) undergoing concurrent PV-SMV resection (VR). Median overall survival post-operation was 22.4 months. LR occurred in 121 patients (60%) at a median time of 8 months postoperatively. Resectable disease exhibited significantly longer local-recurrence free survival compared to borderline resectable/locally advanced pancreatic cancer (BRPC/LAPC) (median 14.5 vs. 7 months, p < 0.001). The most frequent sites of LR were the mesenteric root (37%), superior mesenteric artery (SMA, 21%), and superior mesenteric vein (SMV, 16%), with similar patterns observed in the VR and non-VR groups. BRPC, LAPC, postoperative CA19-9 above normal range, venous thrombosis, and stenosis were associated with LR (HR: 2.1 [95% CI 1.21–3.68], 2.7 [95% CI 1.6–4.71], 1.8 [95% CI 1.21–2.69], 2.0 [95% CI 1.08–3.92], and 1.6 [95% CI 1.0–2.65], respectively), while PV-SMV resection and enlargement of PV-SMV angle were protective factors (HR: 0.4 [95% CI 0.25–0.67] and 0.3 [95% CI 0.19–0.53]).
Conclusions
Despite aggressive treatment strategies including neoadjuvant therapy and radical surgery, LR in pancreatic cancer remains a challenge. This study highlights potential risk factors, recurrence patterns, and associated vascular features for early identification. These findings may guide clinicians in developing more targeted surveillance strategies and inform future research on preventing LR.